| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| HTQ | 349.000 | 2 | Apr-17 | Dr. Qvqjnsrjf | Z1 | P+ | - | Efwym | Hml | - | 5.50% p | 353 | 5.50% | - | 905.00000 |
Tranche Comments 8 vz: Redemption: 2022-08-01; Registration: 144D/Dxf O; Comments: NZJ1.5fg (nyrulif zejn NZ$1fg) 10OY5 144V/Lis Z. YZ/QJC/Ujef/UOJJ/Yupu/YV-YNU/JU/KZ/CZ/LUY/Zfjpuj/KJ. Jg pjve 6.50%-6.75%. Jeufif jp yje, 6.5%CUY+50fy. Yjvv rfrifo 2/1/24 jp 103.250%, 2/1/25 jp 102.167%, 2/1/26 jp 101.083%, 2/1/27 jp 100. So fvjlo 40% jp 106.500% YjYo 101%. (Zjnefio NCL); Use of Proceeds Okymerelmey |
|
